Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

168 results
Display

Changing the strategic paradigm for the treatment of adult acute myeloid leukemia

Cheong JW, Min YH

Background: Acute myeloid leukemia (AML) is a representative blood cancer, accounting for most adult leukemia cases in Korea. Until recently, intensive chemotherapy and hematopoietic stem cell transplantation were the only...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review

Mansour RO, El-Ashwah S, Denewer M

This study aimed to delineate the possible impact of COVID-19 on acute myeloid leukemia (AML) patients in terms of diagnosis, chemotherapy, bone marrow transplant, and vaccination response. Allogeneic stem cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Experience of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients Aged 60 Years and Older in South Korea

Ji YS, Ahn JS, Yun J, Jang GH, Lim SH, Kim SH, Kim CK, Won JH, Park SK

Purpose: The purpose of this study is to share our outcomes and experiences on allogeneic hematopoietic stem cell transplantation (HSCT) in elderly patients aged 60 years and older with myelodysplastic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnostic Approach for Acute Myeloid Leukemia Based on the World Health Organization Classification of Hematologic Neoplasms

Cho YU

Acute myeloid leukemias (AMLs) are heterogeneous hematologic neoplasms characterized by myeloblast or promyelocyte proliferation without normal differentiation. The World Health Organization (WHO) classifies AMLs on the basis of chromosomal and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study

Lee JW, Yoo JW, Kim S, Jang PS, Chung NG, Cho B

Purpose Approximately 30%-40% of pediatric acute myeloid leukemia (AML) patients relapse. In this study, we analyzed the outcome and prognostic factors of relapsed AML patients who had previously received first-line...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Novel Germline Mutation in DDX41 Predisposed to Myelodysplasia/Acute Myeloid Leukemia

Kwak MS, Jeong IH, Kim SH, Kim N

Germline DDX41lesions indicate a hereditary myelodysplastic syndrome and acute myeloid leukemia (MDS/AML). Canonical somatic mutations in this gene often coincide as a second hit with germline DDX41mutations. We report a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Large Vessel Vasculitis as an Initial Manifestation of Acute Myeloid Leukemia: A Case Report

Jeon G, Yang D, Jang J, Kang J

Large vessel vasculitis is characterized by chronic inflammation within the aortic wall and its major branches. The inflammation is considered to occur as a result of immune dysregulation. Hematologic malignancy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bullous Variant of Pyoderma Gangrenosum in a Patient with Acute Myeloid Leukemia

Kwon CI, Lee GW, Kim CY

Unlike classic pyoderma gangrenosum (PG), the bullous variant of PG is typically represented by a painful erythematous papule, plaque, and superficial bulla that progress into the ulceration with bullous margin....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Human acute myeloid leukemia stem cells: evolution of concept

Shin DY

The history of human acute myeloid leukemia stem cells (AMLSCs) began in a seminal study performed by Lapidot and Dick, proving that only CD34+CD38- human primary acute myeloid leukemia (AML)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs

Ahn JS, Kim HJ

FMS-like tyrosine kinase 3 (FLT3) mutations, the most frequently detected genetic aberrations in patients with acute myeloid leukemia (AML), are identified in approximately 30% of patients with newly diagnosed AML...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea

Choi YB, Yoo KH

Purpose Children with Down syndrome (DS) show a higher risk of acute leukemia than those without DS. In this study, we investigated the nationwide incidence of acute leukemia among children with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Myeloid Sarcoma Preceding the Diagnosis of Acute Myeloid Leukemia

Lee YY, Yim SH, Hong D, Jung KE, Lee Y, Seo YJ, Park SH

  • KMID: 2527688
  • Korean J Dermatol.
  • 2022 Mar;60(3):197-199.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Erythema Nodosum Associated with Relapse in Acute Myeloid Leukemia

Yun J, Bae KN, Son JH, Kim H, Ko H, Kim B, Kim MB, Shin K

  • KMID: 2527684
  • Korean J Dermatol.
  • 2022 Mar;60(3):190-191.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
IDH1/2 mutations in acute myeloid leukemia

Byun JM, Yoo SJ, Kim HJ, Ahn JS, Koh Y, Jang JH, Yoon SS

The mutational and epigenetic landscape of acute myeloid leukemia (AML) has become increasingly well understood in recent years, informing on biological targets for precision medicine. Among the most notable findings...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
JAK2V617F-Positive Acute Myeloid Leukemia: Clinicopathological Features of Two Cases

Lee Y, Lee JY, Lee JO, Bang SM, Hwang SM

Although the JAK2V617F mutation is a common genetic basis for the BCR-ABL1-negative myeloproliferative neoplasm (MPN), it is very rarely observed in acute myeloid leukemia (AML) without antecedent MPN. While JAK2V617F...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Venetoclax with Azacitidine Induced Tumor Lysis Syndrome in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

Kim M, Bang HJ, Song GY, Ahn SY, Jung SH, Song YS, Ahn JS

Combination treatment with hypomethylating agents (HMAs) and venetoclax is being used increasingly in elderly patients with acute myeloid leukemia (AML). Venetoclax with HMAs has been reported to be associated with tumor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapy-Related Acute Myeloid Leukemia Diagnosed at Postmortem in a Long-term Survivor of Advanced Hepatocellular Carcinoma

Lee KR, Paik JH, Lee SD, Kim MY

Acute myeloid leukemia (AML) is a common hematologic malignancy with high mortality and a short survival period in adults. About 10% of these cases, called therapy-related AML, are reported to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phospholipase C Beta 2 Protein Overexpression Is a Favorable Prognostic Indicator in Newly Diagnosed Normal Karyotype Acute Myeloid Leukemia

Park MS, Lee YE, Kim HR, Shin JH, Cho HW, Lee JH, Shin MG

Phospholipase C beta 2 (PLC-β2) regulates various essential functions in cell signaling, differentiation, growth, and mobility. We investigated the clinical implications of PLC-β2 protein expression in newly diagnosed normal karyotype...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transfusion Dependency in Patients with Acute Myeloid Leukemia during Induction Chemotherapy

Park HS, Shin KS, Son BR

Background: Blood transfusion is frequently performed as a supportive therapy during the diagnosis and chemotherapy of acute myeloid leukemia (AML). This study examined the frequency of blood transfusion and analyzed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Case Report of Acute Myeloid Leukemia with MN1-ETV6 Rearrangement at Relapse

Lee JJ, Cho HE, Park KS, Kim YJ, Cho SY, Han JJ, Lee WI, Park TS

MN1-ETV6 rearrangement is rarely detected in patients with myeloid neoplasms, such as acute myeloid leukemia, myelodysplastic syndrome, and myelodysplastic/myeloproliferative neoplasms. Usually, MN1-ETV6 rearrangement is found at diagnosis. Here, we report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr